The present study aims to establish a method for determination of salidroside in plasma and tissues of mice, and to study the pharmacokinetics and distribution characteristics of salidroside in mice. After intragastrically administered of salidroside at doses of 12.30, 36.90 and 73.80 mg·kg~(-1) to mice, plasma and tissue samples were collected, and the concentration of salidroside in each sample was measured by UPLC-MS/MS to study plasma drug parameters and tissue distribution of salidroside. Salidroside showed a good linear relationship in the plasma and tissues of mice in the concentration range of 43.40-5 556 ng·mL~(-1). The intraday and interday precision are less than 15%, and the accuracy is between 79.50% and 98.20%. The tissue distribution study found that salidroside had higher plasma concentration, and the plasma concentration reached the maximum at 0.5 h. After 6 h, no salidroside was detected in the plasma, indicating that salidroside has good solubility and absorption fast, clearance is also fast. In tissues, the concentration of liver and kidney tissues is higher, indicating that salidroside liver and kidney are the main metabolic and excretory organs. The established method is easy to operate and has good precision. It is suitable for salidroside in mice. Pharmacokinetics and tissue distribution studies provide a reference for the mechanism of action and drug development of salidroside.
Keywords: UPLC-MS/MS; pharmacokinetics; salidroside; tissue distribution.